Sign in
Taking people in United StatesNo phase

Studies genes linked to problems after heart surgery

Looks for genetic causes of complications, such as atrial fibrillation, after heart surgery.

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, Dallas, and Houston, United StatesSee the 3 sites
Trial code
Registry title
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Status
Recruiting
People taking part
4,000 people, planned
Started
Aug 2000
Expected to end
Aug 2030
Type of study
Observational
Record updated
22 August 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having heart surgery at Brigham and Women's Hospital or Texas Heart Institute. It studies genes that may cause problems after heart surgery.

Age
20 Years to 90 Years
Sex
All sexes can join.
Disease stage
People who are having heart surgery.

Main reasons for not taking part

  • Being enrolled in another drug or device trial that does not allow joining a second trial
  • Not willing to give consent

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Undergoing heart surgery
  • Willing to provide consent

Who cannot take part

  • Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 90 years old?

Where in United States

  • Brigham and Women's HospitalBoston, United StatesNo longer taking part
  • UT Southwestern Medical CenterDallas, United StatesContact: Amanda A Fox, MDTaking people
  • Department Texas Heart Institute at St. Luke's Episcopal HospitalHouston, United StatesNo longer taking part

About the trial

What the trial wants to find out

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Read full original descriptionShow less

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

The group in the trial

  • Cardiac surgery

    Adult patients undergoing cardiac surgery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Plain-language title
Studies genes linked to problems after heart surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT01258231, who can take part
Record updated
22 August 2024